UNITED STATES SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): December 20, 2005
 
GAMMACAN INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
 
Delaware
(State or other jurisdiction of incorporation)
 
0-32835
(Commission File Number)
 
33-0956433
(IRS Employer Identification No.)
 
11 Ben Gurion St., 54100 Givat Shmuel, Israel
(Address of principal executive offices and Zip Code)
 
Registrant's telephone number, including area code: 972 3 5774475
 
 
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

 

Item 3.02 Unregistered Sales of Equity Securities.

On December 20, 2005, we completed a private placement offering of 1,333,334 units to an accredited investor for an aggregate purchase price of $1,000,000.50. Each unit consisted of one share of our common stock, par value $0.001 per share and one warrant to purchase one share of our common stock. The aforementioned securities were sold in reliance upon the exemption afforded by the provisions of Regulation D, as promulgated by the Securities and Exchange Commission under the Securities Act of 1933, as amended.

With respect to the foregoing issuance, two placement agents will each receive $50,000 and 66,666 warrants to purchase one share of our common stock.

In addition, on December 20, 2005, we completed a private placement offering of 222,222 units for an aggregate purchase price of $199,999.80. Each consisted of one share of our common stock, par value $0.001 per share and one warrant to purchase half a share of our common stock. The aforementioned units were sold in reliance upon the exemption afforded by the provisions of Regulation S under the Securities Act.

The purchaser who received shares under Regulation S are non U.S. persons as defined in Rule 902(k) of Regulation S, and no sales efforts were conducted in the U.S., in accordance with Rule 903(c). Such purchasers acknowledged that the securities purchased must come to rest outside the U.S., and the certificates contain a legend restricting the sale of such securities until the Regulation S holding period is satisfied.
 
- 2 -

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
     
  GAMMACAN INTERNATIONAL, INC.
 
 
 
 
 
 
  By:   /s/ VERED CAPLAN
 
Vered Caplan,
  Chief Executive Officer
   
  Date: December 22, 2005
 
 
 
- 3 -